but might have benefited from admission to a specialized unit. The occurrence of arrhythmias was not a marked feature of this series, and this may be the reason for the low mortality rate in those who survived the initial period of infarction. The stress of awaiting the ambulance, the journey often down steep and narrow stairs, and the subsequent ride to hospital may predispose to arrhythmias and contribute to the high mortality rate seen in the first few hours after admission. The advantage of treatment at home, particularly in the early stages, is that it avoids the moving of an ill patient to hospital under difficult circumstances. If number of patients given vasopressin injection and those given placebo who showed no reaction (grade 1) is definitely not significant, and it can therefore be assumed that vasopressin does not affect the incidence of reactions to lumbar puncture. For those showing no reaction (grade 1) P was not significant.
The data in Table I cannot be further analysed, since the numbers in some of the cells are not adequate for the requirements of statistical tests. The effects of the two drugs have therefore been compared in Table II by combining the numbers showing no reaction or only a mild reaction (grades 1 and 2) and the numbers showing more severe reaction (grades 3 and 4). By the Fisher exact probability test the expectation of results as extreme as these by chance is 0.18 for a one-tailed test. This is definitely outside the generally accepted 5% level of significance, but the data do suggest a weak trend towards a reduced severity of reaction due to vasopressin injection. Side-effects of diarrhoea, abdominal cramps, and sweating occurred with varying degrees of severity in seven (27 %) patients on vasopressin injection and onre (4%) patient on placebo. In six of these cases, including the single patient on placebo, the side-effects were so severe as to prevent the completion of the course of injections. The side-effects were significantly more frequent in the patients on vasopressin injection (P=0.032, one-tailed, by the Fisher exact probability test).
Discussion
The headache which follows lumbar puncture is thought to be due to the continued leakage of cerebrospinal fluid (C.S.F.) through the hole in the theca made by the needle. The subsequent low pressure in the C.S.F. pathways is thought to induce pain by traction on the pain-sensitive neural endings in the dura and intracranial venous sinuses and arteries. Hypothetically, vasopressin injection might act by its antidiuretic action, which would tend to retain fluid in all extracellular spaces, including the C.S.F. pathways. The incidence of lumbar puncture headache in four large series cited by Wolff (1963) is 25%. This figure is very similar to our own overall occurrence in 26 % of patients (Table I ). The reaction was mild in half of these subjects.
The present trial shows that the occurrence of any form of reaction to lumbar puncture is unaffected by aqueous vasopressin injection administered in the regimen outlined (Table I) .
Tables II and III indicate a trend that the administration of vasopressin injection is associated with a reduced frequency of severe (grades 3 and 4) reactions. Statistically this almost reaches the accepted 5 % level of significance (P=0.07). However, moderately severe side-effects occurred in 27% of patients given vasopressin injection and in only 4 % given placebo. This suggests that any overall marginal benefit attributable to vasopressin injection is largely offset by the occurrence of sideeffects. Our results do not justify the routine use of vasopressin injection in the prevention of lumbar puncture reactions. However, vasopressin injection may be of value in the treatment of severe reactions to lumbar puncture, but this possibility requires further investigation.
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